慢性肾脏病中静脉血栓栓塞症的机制与缓解因素:REGARDS研究
在REGARDS前瞻性队列的病例-队列研究中,较低eGFR与VTE风险相关(HR 1.13),D-二聚体、因子VIII和C反应蛋白可减弱该关联;他汀、体力活动和华法林在伴与不伴CKD者中均与较低VTE风险相关,而正常BMI仅在不伴CKD者中与较低VTE风险相关。
要点
- eGFR每降低10 mL min-1 1.73 m-2,VTE的HR为1.13(95%CI 1.02-1.25)。
- 因子VIII可100%减弱eGFR与VTE的关联,D-二聚体减弱23%,C反应蛋白减弱15%。
- 他汀、体力活动、华法林在伴与不伴CKD者中均与较低VTE风险相关。
核心结论
- 促凝血和炎症生物标志物介导了eGFR与VTE的关联。
- 较高的体力活动、他汀使用和华法林使用在伴CKD和不伴CKD者中均降低了VTE风险,但正常BMI在CKD患者中未降低VTE风险。
研究设计与样本
- REGARDS研究是一项全国性前瞻性队列研究,纳入30239名年龄≥45岁者,随访4.3年。
- 本分析为病例-队列研究,测量基线生物标志物,包括294例VTE病例和939例非病例。
主要发现
- eGFR降低与VTE的HR为1.13(95%CI 1.02-1.25)。
- D-二聚体使该HR减弱23%(95%CI 5-100),因子VIII减弱100%(95%CI 50-100),C反应蛋白减弱15%(95%CI 2-84)。
- 不伴CKD者中正常BMI与较低VTE风险相关(HR 0.47,95%CI 0.32-0.70),伴CKD者中无此关联(HR 1.07,95%CI 0.51-2.22)。
- 他汀使用、体力活动和华法林使用在两组中均与较低VTE风险相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Essentials Chronic kidney disease (CKD) is associated with procoagulant and inflammatory biomarkers. We studied the association of CKD and venous thromboembolism (VTE) in a case-cohort study. Factor VIII, D-dimer and C-reactive protein appeared to explain the association of CKD and VTE. Statin use was protective against VTE in those with and without CKD. SUMMARY: Background Chronic kidney disease (CKD) is associated with venous thromboembolism (VTE) risk via unknown mechanisms. Whether factors associated with reduced VTE risk in the general population might also be associated with reduced VTE risk in CKD patients is unknown. Objectives To determine whether thrombosis biomarkers attenuate VTE risk, and whether factors associated with reduced VTE risk are similarly effective in CKD patients. Methods Baseline biomarkers were measured in a cohort (294 VTE cases; 939 non-cases) from the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study, a nationwide prospective cohort study of 30 239 persons aged ≥45 years with 4.3 years of follow-up. The hazard ratio (HR) of VTE per 10 mL min-1 1.73 m-2 decrease in estimated glomerular filtration rate (eGFR), and the percentage attenuation of this HR by each biomarker, were calculated. Associations of protective factors (physical activity, lower body mass index [BMI], and aspirin, warfarin and statin use) with VTE were estimated in those with and without CKD. Results The HR for VTE with lower eGFR was 1.13 (95% confidence interval [CI] 1.02-1.25), and VTE risk was attenuated by 23% (95% CI 5-100) by D-dimer, by 100% (95% CI 50-100) by factor VIII, and by 15% (95% CI 2-84) by C-reactive protein. Normal BMI was associated with lower VTE risk in those without CKD (HR 0.47, 95% CI 0.32-0.70), but not in those with CKD (HR 1.07, 95% CI 0.51-2.22). Statin use, physical activity and warfarin use were associated with lower VTE risk in both groups. Conclusions Procoagulant and inflammatory biomarkers mediated the association of eGFR with VTE. Higher physical activity, statin use and warfarin use mitigated VTE risk in those with CKD and those without CKD, but normal BMI did not mitigate VTE risk in CKD patients.
引用
- Cheung KL, Zakai NA, Callas PW, et al. Mechanisms and mitigating factors for venous thromboembolism in chronic kidney disease: the REGARDS study. J Thromb Haemost. 2018. PMID: 29984467. doi:10.1111/jth.14235
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。